Applied Filters
EU court backs medical device company over EUIPO
The EU General Court yesterday, March 20, annulled a European Union Intellectual Property Office (EUIPO) decision and handed a trademark victory to Spain-based Prim.
National Cancer Institute’s director named as acting FDA chief
The Trump administration has named Ned Sharpless, director of the National Cancer Institute, as the Food and Drug Administration's (FDA) acting commissioner.
Novartis fails to secure ‘smart’ TM for contact lenses
Switzerland-based Novartis today, March 12, failed to convince the EU General Court that its ‘Smartsurface’ trademark should be registered for contact lenses.
USITC to investigate blood separation devices
The US International Trade Commission has instituted an investigation into certain blood separation and cell preparation devices.
USITC investigating dental scanners for alleged patent infringement
The US International Trade Commission has begun an investigation into whether a Danish company’s dental and orthodontic scanners and software infringed an American company’s patents.
Immunity can’t protect university from patent challenge: Fed Circuit
The US Court of Appeals for the Federal Circuit yesterday rejected the University of Florida’s argument that its sovereign immunity protected a patent from section 101 scrutiny.
ResMed and Fisher & Paykel settle patent disputes
American medical device maker ResMed and New Zealand-based competitor Fisher & Paykel have agreed to settle a global patent dispute over medical devices.
J&J to buy surgical robotics company for $3.4bn
Johnson & Johnson has announced plans to strengthen its robotics programme with the addition of Silicon Valley-based Auris Health to its business.
EU court throws out dentistry TM application
The EU General Court has dismissed an appeal from German company Nemius Group against a decision to refuse registration for its ‘Dentaldisk’ mark.
Clarivate announces new Life Science Alliances programme
Global information company Clarivate Analytics has launched a “Life Science Alliances Program” to provide drug and medical device developers a new way to advance their research and development.
